Abbott Laboratories vs. Phathom Pharmaceuticals, Inc. Common Stock
ABT
Abbott Laboratories
$104.88 +1.14%
VS PHATPhathom Pharmaceuticals, Inc. Common Stock
$5.94 +3.48%
Abbott Laboratories and Phathom Pharmaceuticals, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | PHAT | |
|---|---|---|
| Market Cap | $179.44 billion | $464.37 million |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | PHAT | |
|---|---|---|
| Dividend Yield | 2.40% | — |
ABT and PHAT split the dividend factors evenly.
Risk & Sentiment
| ABT | PHAT | |
|---|---|---|
| Short Interest | 0.57% | 0.01% |
PHAT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, PHAT overview, PHAT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.